Non-Surgical Bleeding and Transurethral Resection of the Prostate (TURP) Syndrome after TURP Surgery: A Case Report and Literature Review
Abstract
1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Stewart, K.L.; Lephart, E.D. Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome. Int. J. Mol. Sci. 2023, 24, 5486. [Google Scholar] [CrossRef]
- Ottaiano, N.; Shelton, T.; Sanekommu, G.; Benson, C.R. Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment. Curr. Urol. Rep. 2022, 23, 83–92. [Google Scholar] [CrossRef]
- Awedew, A.F.; Han, H.; Abbasi, B.; Abbasi-Kangevari, M.; Ahmed, M.B.; Almidani, O.; Amini, E.; Arabloo, J.; Argaw, A.M.; Athari, S.S.; et al. The Global, Regional, and National Burden of Benign Prostatic Hyperplasia in 204 Countries and Territories from 2000 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2022, 3, e754–e776. [Google Scholar] [CrossRef]
- Parsons, J.K.; Dahm, P.; Köhler, T.S.; Lerner, L.B.; Wilt, T.J. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020. J. Urol. 2020, 204, 799–804. [Google Scholar] [CrossRef]
- Reich, O.; Gratzke, C.; Bachmann, A.; Seitz, M.; Schlenker, B.; Hermanek, P.; Lack, N.; Stief, C.G.; Urology Section of the Bavarian Working Group for Quality Assurance. Morbidity, Mortality and Early Outcome of Transurethral Resection of the Prostate: A Prospective Multicenter Evaluation of 10,654 Patients. J. Urol. 2008, 180, 246–249. [Google Scholar] [CrossRef]
- Rassweiler, J.; Teber, D.; Kuntz, R.; Hofmann, R. Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention. Eur. Urol. 2006, 50, 969–980. [Google Scholar] [CrossRef]
- Beattie, G.W.; Hooks, G.J.; Mhandu, P.C.E.; Parissis, H. Non-Surgical Bleeding in Cardiac Surgery. Oxf. Med. Case Rep. 2016, 2016, omw053. [Google Scholar] [CrossRef]
- Geisen, U.; Heilmann, C.; Beyersdorf, F.; Benk, C.; Berchtold-Herz, M.; Schlensak, C.; Budde, U.; Zieger, B. Non-Surgical Bleeding in Patients with Ventricular Assist Devices Could Be Explained by Acquired von Willebrand Disease. Eur. J. Cardiothorac. Surg. 2008, 33, 679–684. [Google Scholar] [CrossRef]
- Menzebach, A.; Cassens, U.; Aken, H.V.; Booke, M. Strategies to Reduce Perioperative Blood Loss Related to Non-Surgical Bleeding. Eur. J. Anaesthesiol. 2005, 20, 764–770. [Google Scholar] [CrossRef]
- Celander, D.R.; Guest, M.M. The Biochemistry and Physiology of Urokinase. Am. J. Cardiol. 1960, 6, 409–419. [Google Scholar] [CrossRef]
- Ole Kjeldgaard, N.; Ploug, J. Urokinase an Activator of Plasminogen from Human Urine II. Mechanism of Plasminogen Activation. Biochim. Biophys. Acta 1957, 24, 283–289. [Google Scholar] [CrossRef] [PubMed]
- Wada, Y.; Uchiba, M.; Kawano, Y.; Kai, N.; Takahashi, W.; Honda, J.; Tanoue, K.; Maeda, Y.; Murakami, Y.; Eto, M.; et al. Severe Bleeding Tendency Caused by a Rare Complication of Excessive Fibrinolysis with Disseminated Intravascular Coagulation in a 51-Year-Old Japanese Man with Prostate Cancer: A Case Report. J. Med. Case Rep. 2012, 6, 378. [Google Scholar] [CrossRef] [PubMed]
- Gravenstein, D. Transurethral Resection of the Prostate (TURP) Syndrome: A Review of the Pathophysiology and Management. Anesth. Analg. 1997, 84, 438–446. [Google Scholar] [CrossRef]
- Al-Hajjaj, M.; Kanjo, M.; Tallaa, M. TURP Syndrome: A Rare Case Report from Syria. Int. J. Surg. Case Rep. 2022, 93, 107021. [Google Scholar] [CrossRef]
- Singh, S.; Kumar, N.; Paul, D.; Sasidharan, S. A Case of Operative Hysteroscopy Intravascular Absorption Syndrome: Gynaecological TURP Syndrome. Indian J. Anaesth. 2021, 65, 167. [Google Scholar] [CrossRef] [PubMed]
- Macfarlane, R.G.; Pilling, J. Fibrinolytic Activity of Normal Urine. Nature 1947, 159, 779. [Google Scholar] [CrossRef]
- Charlton, C.A.C. Fibrinolytic Activity in Blood and Urine. J. Clin. Pathol. 1966, 19, 238–240. [Google Scholar] [CrossRef] [PubMed]
- Rijken, D.C.; Wijngaards, G.; Welbergen, J. Immunological Characterization of Plasminogen Activator Activities in Human Tissues and Body Fluids. J. Lab. Clin. Med. 1981, 97, 477–486. [Google Scholar]
- Sgouris, J.T.; Inman, J.K.; McCall, K.B. The Preparation of Human Urokinase. Am. J. Cardiol. 1960, 6, 406–408. [Google Scholar] [CrossRef]
- Ploug, J.; Kjeldgaard, N.O. Isolation of a Plasminogen Activator (Urokinase) from Urine. Arch. Biochem. Biophys. 1956, 62, 500–501. [Google Scholar] [CrossRef]
- Brown, W.; Lyden, P.D. Intravenous Thrombolysis. In Stroke; Elsevier: Amsterdam, The Netherlands, 2016; pp. 826–848. ISBN 978-0-323-29544-4. [Google Scholar]
- Kharel, S.; Nepal, G.; Joshi, P.R.; Yadav, J.K.; Shrestha, T.M. Safety and Efficacy of Low-Cost Alternative Urokinase in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. J. Clin. Neurosci. 2022, 106, 103–109. [Google Scholar] [CrossRef] [PubMed]
- Zhang, R.; Wei, H.; Ren, Y.; Wu, Y.; Luo, Y.; Zhang, L.; Huo, Y.; Feng, J.; Monnier, P.P.; Qin, X. Outcomes and Treatment Complications of Intravenous Urokinase Thrombolysis in Acute Ischemic Stroke in China. Front. Neurol. 2021, 12, 685454. [Google Scholar] [CrossRef] [PubMed]
- Bao, H.; Gao, H.-R.; Pan, M.-L.; Zhao, L.; Sun, H.-B. Comparative Study on the Efficacy and Safety of Alteplase and Urokinase in the Treatment of Acute Cerebral Infarction. Technol. Health Care 2021, 29, 85–90. [Google Scholar] [CrossRef] [PubMed]
- Yin, X.-S.; Huang, Y.-W.; Li, Z.-P.; Dong, J.-L.; Zou, J.-M.; Tian, L.; Yang, J. Efficacy and Safety of Intracoronary Pro-Urokinase Injection during Percutaneous Coronary Intervention in Treating ST Elevation Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 5802–5813. [Google Scholar] [CrossRef] [PubMed]
- Sugg, R.M.; Noser, E.A.; Shaltoni, H.M.; Gonzales, N.R.; Campbell, M.S.; Weir, R.; Cacayorin, E.D.; Grotta, J.C. Intra-Arterial Reteplase Compared to Urokinase for Thrombolytic Recanalization in Acute Ischemic Stroke. AJNR Am. J. Neuroradiol. 2006, 27, 769–773. [Google Scholar] [PubMed]
- Sun, F.; Liu, H.; Fu, H.; Zhang, S.; Qian, X.; Li, J.; Zhu, Y.; Zhang, X.; Zhang, J.; Qiu, H.; et al. Comparative Study of Intravenous Thrombolysis with Rt-PA and Urokinase for Patients with Acute Cerebral Infarction. J. Int. Med. Res. 2020, 48, 030006051989535. [Google Scholar] [CrossRef] [PubMed]
- Śmiłowska, K.; Śmiłowski, M.; Partyka, R.; Kokocińska, D.; Jałowiecki, P. Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor. J. Pers. Med. 2022, 12, 457. [Google Scholar] [CrossRef] [PubMed]
- Sandø, A.; Schultz, M.; Eugen-Olsen, J.; Køber, L.; Engstrøm, T.; Kelbæk, H.; Jørgensen, E.; Saunamäki, K.; Holmvang, L.; Pedersen, F.; et al. Soluble Urokinase Receptor as a Predictor of Non-Cardiac Mortality in Patients with Percutaneous Coronary Intervention Treated ST-Segment Elevation Myocardial Infarction. Clin. Biochem. 2020, 80, 8–13. [Google Scholar] [CrossRef]
- Nielsen, J.D.; Gram, J.; Holm-Nielsen, A.; Fabrin, K.; Jespersen, J. Post-operative Blood Loss after Transurethral Prostatectomy Is Dependent on in Situ Fibrinolysis. Br. J. Urol. 1997, 80, 889–893. [Google Scholar] [CrossRef]
- Ziegler, S.; Ortu, A.; Reale, C.; Proietti, R.; Mondello, E.; Tufano, R.; Di Benedetto, P.; Fanelli, G. Fibrinolysis or Hypercoagulation during Radical Prostatectomy? An Evaluation of Thrombelastographic Parameters and Standard Laboratory Tests. Eur. J. Anaesthesiol. 2008, 25, 538–543. [Google Scholar] [CrossRef]
- Tawfick, A.; Mousa, W.; El-Zhary, A.F.; Saafan, A.M. Can Tranexamic Acid in Irrigation Fluid Reduce Blood Loss during Monopolar Transurethral Resection of the Prostate? A Randomised Controlled Trial. Arab J. Urol. 2022, 20, 94–99. [Google Scholar] [CrossRef] [PubMed]
- Karkhanei, B.; Musavi-Bahar, S.H.; Bayat, M.; Kaseb, K.; Rezaee, H.; Moradi, A.; Moradi, M. Safety and Efficacy of Intraoperative Administration of Intravenous Tranexamic Acid in Transurethral Resection of Prostate: A Double-Blind, Randomised, Placebo-Controlled Trial. J. Clin. Urol. 2020, 13, 125–131. [Google Scholar] [CrossRef]
- Samir, M.; Saafan, A.M.; Afifi, R.M.; Tawfick, A. Can High-Dose Tranexamic Acid Have a Role during Transurethral Resection of the Prostate in Large Prostates? A Randomised Controlled Trial. Arab J. Urol. 2022, 20, 24–29. [Google Scholar] [CrossRef] [PubMed]
- Pranata, F.; Kloping, Y.; Hidayatullah, F.; Rahman, Z.; Yogiswara, N.; Rahman, I.; Febriansyah, N.; Soebadi, D. The Role of Tranexamic Acid in Reducing Bleeding during Transurethral Resection of the Prostate: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Indian J. Urol. 2022, 38, 258. [Google Scholar] [CrossRef] [PubMed]
- Pourfakhr, P.; Gatavi, E.; Gooran, S.; Etezadi, F.; Khajavi, M.R.; Pourroustaei, R.; Shariat Moharari, R.; Najafi, A. Local Administration of Tranexamic Acid during Prostatectomy Surgery: Effects on Reducing the Amount of Bleeding. Nephro-Urol. Mon. 2016, 8, e40409. [Google Scholar] [CrossRef]
- Bansal, A.; Arora, A. A Double-Blind, Placebo-Controlled Randomized Clinical Trial to Evaluate the Efficacy of Tranexamic Acid in Irrigant Solution on Blood Loss during Percutaneous Nephrolithotomy: A Pilot Study from Tertiary Care Center of North India. World J. Urol. 2017, 35, 1233–1240. [Google Scholar] [CrossRef]
- Gupta, A.; Priyadarshi, S.; Vyas, N.; Sharma, G. Efficacy of Tranexamic Acid in Decreasing Primary Hemorrhage in Transurethral Resection of the Prostate: A Novel Combination of Intravenous and Topical Approach. Urol. Ann. 2021, 13, 238. [Google Scholar] [CrossRef]
- Jendoubi, A.; Malouch, A.; Bouzouita, A.; Riahi, Y.; Necib, H.; Ghedira, S.; Houissa, M. Intérêt de l’acide tranexamique dans les résections endoscopiques urologiques: Étude prospective randomisée. Prog. En Urol. 2017, 27, 1036–1042. [Google Scholar] [CrossRef]
- Rannikko, A.; Pétas, A.; Taari, K. Tranexamic Acid in Control of Primary Hemorrhage during Transurethral Prostatectomy. Urology 2004, 64, 955–958. [Google Scholar] [CrossRef]
- Meng, Q.; Pan, N.; Xiong, J.; Liu, N. Tranexamic Acid Is Beneficial for Reducing Perioperative Blood Loss in Transurethral Resection of the Prostate. Exp. Ther. Med. 2018, 17, 943–947. [Google Scholar] [CrossRef]
- Kumsar, Ş.; Dirim, A.; Toksöz, S.; Sağlam, H.S.; Adsan, Ö. BPH Tranexamic Acid Decreases Blood Loss during Transurethral Resection of the Prostate (TUR-P). Cent. Eur. J. Urol. 2011, 64, 156–158. [Google Scholar] [CrossRef] [PubMed]
- Vanderbruggen, W.; Brits, T.; Tilborghs, S.; Derickx, K.; De Wachter, S. The Effect of Tranexamic Acid on Perioperative Blood Loss in Transurethral Resection of the Prostate: A Double-blind, Randomized Controlled Trial. Prostate 2023, 83, 1584–1590. [Google Scholar] [CrossRef] [PubMed]
- Mohammadi Sichani, M.; Mohammadi, S.; Khorrami, M.; Zargham, M.; Javid, A.; Dehghani, M.; Gholipour, F.; Dehkordi, P.; Kazemi, R. Evaluating the Effectiveness of Tranexamic Acid Administration in Reducing Bleeding in Benign Prostate Hyperplasia Patients Underwent Open Prostatectomy: A Double-Blind Randomized Clinical Trial. J. Res. Med. Sci. 2023, 28, 8. [Google Scholar] [CrossRef] [PubMed]
- Cozzi, P.; Wang, J.; Delprado, W.; Madigan, M.; Fairy, S.; Russell, P.; Li, Y. Evaluation of Urokinase Plasminogen Activator and Its Receptor in Different Grades of Human Prostate Cancer☆. Hum. Pathol. 2006, 37, 1442–1451. [Google Scholar] [CrossRef] [PubMed]
- Jensen, V. The TURP Syndrome. Can. J. Anaesth. 1991, 38, 90–97. [Google Scholar] [CrossRef] [PubMed]
- Yousef, A.A.; Suliman, G.A.; Elashry, O.M.; Elsharaby, M.D.; Elgamasy, A.E.K. A Randomized Comparison between Three Types of Irrigating Fluids during Transurethral Resection in Benign Prostatic Hyperplasia. BMC Anesthesiol. 2010, 10, 7. [Google Scholar] [CrossRef]
- Aasheim, G.M. Hyponatraemia during Transurethral Surgery. Can. Anaesth. Soc. J. 1973, 20, 274–280. [Google Scholar] [CrossRef] [PubMed]
- Corson, S.L. Hyponatremic Encephalopathy after Endometrial Ablation. JAMA J. Am. Med. Assoc. 1994, 271, 343–344. [Google Scholar] [CrossRef]
- Rosenberg, M.K. Hyponatremic Encephalopathy after Rollerball Endometrial Ablation. Anesth. Analg. 1995, 80, 1046–1048. [Google Scholar] [CrossRef]
- Yende, S.; Wunderink, R. An 87-Year-Old Man with Hypotension and Confusion after Cystoscopy. Chest 1999, 115, 1449–1451. [Google Scholar] [CrossRef]
- Hahn, R.G. Transurethral Resection Syndrome from Extravascular Absorption of Irrigating Fluid. Scand. J. Urol. Nephrol. 1993, 27, 387–394. [Google Scholar] [CrossRef] [PubMed]
- Nakahira, J.; Sawai, T.; Fujiwara, A.; Minami, T. Transurethral Resection Syndrome in Elderly Patients: A Retrospective Observational Study. BMC Anesthesiol. 2014, 14, 30. [Google Scholar] [CrossRef] [PubMed]
- Gupta, K.; Rastogi, B.; Jain, M.; Gupta, P.; Sharma, D. Electrolyte Changes: An Indirect Method to Assess Irrigation Fluid Absorption Complications during Transurethral Resection of Prostate: A Prospective Study. Saudi J. Anaesth. 2010, 4, 142. [Google Scholar] [CrossRef] [PubMed]
- Kumar, V.; Vineet, K.; Deb, A. TUR Syndrome—A Report. Urol. Case Rep. 2019, 26, 100982. [Google Scholar] [CrossRef]
Reference | Authors | Year | Dose of Tranexamic Acid | Method of Injection | Time of Injection |
---|---|---|---|---|---|
[42] | Kumsar et al. | 2011 | 10 mg/kg | Intravenous | Operative |
[40] | Rannikko et al. | 2004 | 2 g | Oral | Operative and first postoperative day |
[39] | Jendoubi et al. | 2017 | 10 mg/kg | Intravenous | Preoperative, intraoperative |
[41] | Meng et al. | 2018 | 1 g | Intravenous | Preoperative |
[33] | Karkhanei et al. | 2020 | 500 mg | Intravenous | Preoperative |
[38] | Gupta et al. | 2021 | 500 mg | Intravenous | Preoperative |
[34] | Samir et al. | 2022 | 50 mg/kg | Intravenous | Preoperative |
[32] | Tawfick et al. | 2022 | 0.1% TXA 1000 mg (10 mL) in 1 L of irrigation solution during surgery, 500 mg of TXA (5 mL) in 100 mL of normal saline solution at the end of surgery | In the irrigation fluid during the surgery, injection locally into the bladder at the end of surgery | Operative |
[43] | Vanderbruggen et al. | 2023 | loading dose of 10 mg/kg, followed by a maintenance dose of 5 mg/kg/h | Intravenous | Operative, postoperative |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Eraky, A.M.; Rubenstein, S.C.; Khan, A.; Mokhtar, Y.; Gregorich, N.M. Non-Surgical Bleeding and Transurethral Resection of the Prostate (TURP) Syndrome after TURP Surgery: A Case Report and Literature Review. Pathophysiology 2024, 31, 367-375. https://doi.org/10.3390/pathophysiology31030027
Eraky AM, Rubenstein SC, Khan A, Mokhtar Y, Gregorich NM. Non-Surgical Bleeding and Transurethral Resection of the Prostate (TURP) Syndrome after TURP Surgery: A Case Report and Literature Review. Pathophysiology. 2024; 31(3):367-375. https://doi.org/10.3390/pathophysiology31030027
Chicago/Turabian StyleEraky, Akram M., Sidney C. Rubenstein, Adnan Khan, Yasser Mokhtar, and Nicole M. Gregorich. 2024. "Non-Surgical Bleeding and Transurethral Resection of the Prostate (TURP) Syndrome after TURP Surgery: A Case Report and Literature Review" Pathophysiology 31, no. 3: 367-375. https://doi.org/10.3390/pathophysiology31030027
APA StyleEraky, A. M., Rubenstein, S. C., Khan, A., Mokhtar, Y., & Gregorich, N. M. (2024). Non-Surgical Bleeding and Transurethral Resection of the Prostate (TURP) Syndrome after TURP Surgery: A Case Report and Literature Review. Pathophysiology, 31(3), 367-375. https://doi.org/10.3390/pathophysiology31030027